Delivery Order SPE2DB22D9239-SPE2DB24FDJ71
Award Date 5/16/24
Potential Completion Date 6/7/24
Potential Value $118K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $59,144.16, is for the delivery of 300 mg vials of Entyvio, a prescription biologic medication. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue firm...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $115,494.24, is for the delivery of Entyvio 300 mg vials. The contract has no set-aside designation. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999 and running through December 31, 2025....
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $118,288.32, is for the delivery of Entyvio 300 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $118,422.75 contract is for the delivery of 300mg vials of the prescription drug Entyvio. The contract is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows for the issuance of firm fixed-price delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $73,930.20 and has an ultimate completion date of July 1, 2024. The contract is for the delivery of the pharmaceutical product Entyvio 300 mg vials to support the recurring medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $29,669.58 and covers the delivery of 300 mg vials of the pharmaceutical drug Entyvio through February 18, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of Entyvio 300 mg vials, a pharmaceutical product. The potential value of the order is $111,200.16, with a completion date of October 15, 2021. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $94,738.20, is for the procurement of 300 mg vials of Entyvio, a specialized pharmaceutical product. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 that DMS Pharmaceutical Group holds...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,449.30 contract is for the delivery of 300 mg vials of the drug Entyvio, with a completion date of August 1, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $29,572.08 and has an ultimate completion date of October 9, 2024. The contract covers the delivery of Entyvio 300 mg vials, a specialty pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDJ71Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. The order, valued at $118,288.32, is for the delivery of 300 mg vials of the pharmaceutical drug Entyvio. The order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.
Generated 8/15/24, 9:30 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $118.3k | 5/16/24 |